BAKER BROS. ADVISORS LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$21.04B2026 Q3
Positions80
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.77.2%

BAKER BROS. ADVISORS LP reported 80 positions worth $21.04B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: INCY (17.7%). Biggest move: reduce CELC ($246.5M).

10 / 80 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 INCYIncyte$3.73B17.74%30,762,652——-0.9%
▸ 2 ONCBeOne Medicines$3.23B15.36%8,832,335——+12.4%
▸ 3 RVMDRevolution Medicines$2.18B10.38%10,637,318——-18.7%
▸ 4 KODKodiak Sciences$2.07B9.85%21,860,941——+6.3%
▸ 5 MDGLMadrigal Pharmaceuticals$1.08B5.13%2,143,131——-15.9%
▸ 6 INSMInsmed$1.00B4.77%8,796,111——+7.7%
▸ 7 KYMRKymera Therapeutics$967.8M4.60%8,657,242——+14.1%
▸ 8 ACADAcadia Pharmaceuticals$864.7M4.11%42,912,904——-6.9%
▸ 9 GRALGrail$564.5M2.68%4,028,614——-17.3%
▸ 10 SMMTSummit Therapeutics$554.4M2.63%32,786,348——-16.3%

Pro Feature

The remaining 70 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does BAKER BROS. ADVISORS LP hold as of Q3 2026?

BAKER BROS. ADVISORS LP reported 80 positions worth $21.04B in its Q3 2026 13F filing. Largest positions: INCY (17.7%), ONC (15.4%), RVMD (10.4%), KOD (9.8%) and MDGL (5.1%).

What did BAKER BROS. ADVISORS LP buy in Q3 2026?

New positions: TRAX, SCTX, FRNM, QTTB and Skye Bioscience, Inc.. Added to: KOD, CLDX, ONC, MPLT and DSGN (9 in all).

What did BAKER BROS. ADVISORS LP sell in Q3 2026?

Reduced: CELC, RVMD, IMVT, STOK and IMTX (11 in all). Sold out entirely: CRNXGBP, ALMS, VRDN, SION and VSTM (9 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.